{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:21:04Z","timestamp":1773811264226,"version":"3.50.1"},"reference-count":44,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Major Project of China","award":["2016ZX09101017"],"award-info":[{"award-number":["2016ZX09101017"]}]},{"name":"National Science and Technology Major Project of China","award":["2-759-02-DR"],"award-info":[{"award-number":["2-759-02-DR"]}]},{"name":"Advanced Research and Training Program of Beijing Double Leading Scholars from China academy of Chinese Medical Science","award":["2016ZX09101017"],"award-info":[{"award-number":["2016ZX09101017"]}]},{"name":"Advanced Research and Training Program of Beijing Double Leading Scholars from China academy of Chinese Medical Science","award":["2-759-02-DR"],"award-info":[{"award-number":["2-759-02-DR"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>TATA box-binding protein-associated factor 12 (TAF12) has been identified as an oncogene in choroid plexus carcinoma, but its role in glioma is poorly understood because of a lack of previous studies. This study investigated the relationship of TAF12 expression with the clinicopathologic features of glioma cases, as well as its prognostic value and biological function, using large-scale databases and clinical samples. TAF12 mRNA expression and clinicopathologic characteristics of glioma cases were assessed in three public databases, and bioinformatics analyses were conducted to explore the prognostic value and biological functions of TAF12 in glioma. High TAF12 expression was commonly associated with reduced survival time and poor clinical indexes, including higher World Health Organization grade, wild-type isocitrate dehydrogenase 1 expression, and 1p19q non-codeletion status (p &lt; 0.0001). Multivariate Cox regression analysis showed that high TAF12 expression was an independent poor prognostic factor for glioma patients (hazard ratio = 1.41, 95% confidence interval, 1.18\u20131.68, p &lt; 0.001). Functional enrichment analysis revealed involvement of TAF12 in immune and inflammatory responses in glioma. Also, expression of several immune checkpoint molecules was significantly higher in samples with high TAF12 expression. TAF12 is a potential independent prognostic factor for glioma, and these findings provide a foundation for further investigation of the potential role of TAF12 in immunotherapy.<\/jats:p>","DOI":"10.3390\/biom12121847","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T02:15:33Z","timestamp":1670811333000},"page":"1847","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated TAF12 Expression Predicts Poor Prognosis in Glioma Patients: Evidence from Bioinformatic and Immunohistochemical Analyses"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8985-4808","authenticated-orcid":false,"given":"Xiaodi","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Neuro-Oncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"},{"name":"Department of Oncology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aizhong","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nursing School, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","article-title":"Clinical practice guidelines for the management of adult diffuse gliomas","volume":"499","author":"Jiang","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1101\/gad.306324.117","article-title":"Downstream promoter interactions of TFIID TAFs facilitate transcription reinitiation","volume":"31","author":"Joo","year":"2017","journal-title":"Genes Dev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"eaau8872","DOI":"10.1126\/science.aau8872","article-title":"Structure of human TFIID and mechanism of TBP loading onto promoter DNA","volume":"362","author":"Patel","year":"2018","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1158\/1541-7786.MCR-07-0375","article-title":"TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells","volume":"6","author":"Voulgari","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ccell.2015.04.005","article-title":"Cross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes","volume":"27","author":"Tong","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_7","first-page":"18090","article-title":"Identifying the genes regulated by IDH1 via gene-chip in glioma cell U87","volume":"8","author":"Ren","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wijethilake, N., Meedeniya, D., Chitraranjan, C., and Perera, I. (2020). Survival Prediction and Risk Estimation of Glioma Patients Using mRNA Expressions, IEEE.","DOI":"10.1109\/BIBE50027.2020.00014"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1158\/0008-5472.CAN-09-2307","article-title":"Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology","volume":"69","author":"Gravendeel","year":"2009","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12974-019-1418-3","article-title":"Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples","volume":"16","author":"Feng","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on Immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"600506","DOI":"10.3389\/fcell.2021.600506","article-title":"Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and 2 Mechanisms of Response and Resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: Current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/sj.emboj.7601550","article-title":"Identification of novel functional TBP-binding sites and general factor repertoires","volume":"26","author":"Denissov","year":"2007","journal-title":"EMBO J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Xu, Y., Milazzo, J.P., Somerville, T.D.D., Tarumoto, Y., Huang, Y.H., Ostrander, E.L., Wilkinson, J.E., Challen, G.A., and Vakoc, C.R. (2018). A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. Cancer Cell, 33.","DOI":"10.1016\/j.ccell.2017.12.002"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1158\/0008-5472.CAN-18-3235","article-title":"Chromosomal Instability in Tumor Initiation and Development","volume":"79","author":"Bach","year":"2019","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1073\/pnas.1611839113","article-title":"Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer","volume":"113","author":"Duffy","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: Balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1101\/gad.294348.116","article-title":"Single tumor-initiating cells evade immune clearance by recruiting type II macrophages","volume":"31","author":"Guo","year":"2017","journal-title":"Genes Dev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","article-title":"Differential macrophage programming in the tumor microenvironment","volume":"33","author":"Ruffell","year":"2012","journal-title":"Trends Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: From basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.2174\/0929867324666170804143706","article-title":"Immune Checkpoint Inhibitors: Basics and Challenges","volume":"26","author":"Li","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-14-0514","article-title":"Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors","volume":"20","author":"Wainwright","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3171\/2015.5.JNS141901","article-title":"Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model","volume":"124","author":"Hanihara","year":"2016","journal-title":"J. Neurosurg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1158\/1078-0432.CCR-14-0820","article-title":"Blocking immunosuppressive checkpoints for glioma therapy: The more the Merrier!","volume":"20","author":"Castro","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Omuro, A., Brandes, A.A., Carpentier, A.F., Idbaih, A., Reardon, D.A., Cloughesy, T., Sumrall, A., Baehring, J., van den Bent, M., and Bahr, O. (2022). Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial. Neuro Oncol., noac099.","DOI":"10.1093\/neuonc\/noac099"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40425-018-0479-7","article-title":"High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors","volume":"6","year":"2018","journal-title":"J. Immunother. Cancer"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/12\/1847\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:37:56Z","timestamp":1760146676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/12\/1847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["biom12121847"],"URL":"https:\/\/doi.org\/10.3390\/biom12121847","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,10]]}}}